Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A - Asset Resilience Ratio

Latest as of June 2025: 6.09%

Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (688212) has an Asset Resilience Ratio of 6.09% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 688212 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥113.00 Million
≈ $16.54 Million USD Cash + Short-term Investments

Total Assets

CN¥1.86 Billion
≈ $271.68 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's Asset Resilience Ratio has changed over time. See Shanghai Aohua Photoelectricity Endoscop book value and equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 688212 market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥113.00 Million 6.09%
Total Liquid Assets CN¥113.00 Million 6.09%

Asset Resilience Insights

  • Limited Liquidity: Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A maintains only 6.09% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 36.63%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
Shanghai Kinetic Medical Co
SHE:300326
Medical Devices 28.89%
Eurobio Scientific SA
PA:ALERS
Medical Devices 10.52%
EBR Systems Inc
AU:EBR
Medical Devices 48.75%
Aroa Biosurgery Ltd
AU:ARX
Medical Devices 12.13%
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
Medical Devices 19.31%
Affluent Medical SAS
PA:AFME
Medical Devices 0.03%

Annual Asset Resilience Ratio for Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (2021–2024)

The table below shows the annual Asset Resilience Ratio data for Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 7.25% CN¥126.81 Million
≈ $18.56 Million
CN¥1.75 Billion
≈ $255.89 Million
-13.66pp
2023-12-31 20.91% CN¥333.60 Million
≈ $48.82 Million
CN¥1.60 Billion
≈ $233.41 Million
-9.45pp
2022-12-31 30.37% CN¥443.40 Million
≈ $64.88 Million
CN¥1.46 Billion
≈ $213.66 Million
+26.96pp
2021-12-31 3.41% CN¥46.03 Million
≈ $6.74 Million
CN¥1.35 Billion
≈ $197.44 Million
--
pp = percentage points

About Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A

SHG:688212 China Medical Devices
Market Cap
$700.74 Million
CN¥4.79 Billion CNY
Market Cap Rank
#10907 Global
#3221 in China
Share Price
CN¥35.56
Change (1 day)
+1.72%
52-Week Range
CN¥34.65 - CN¥56.87
All Time High
CN¥81.71
About

Shanghai Aohua Photoelectricity Endoscope Co., Ltd. engages in the research and development, manufacture, and sale of electronic endoscope equipment and endoscopic diagnosis and treatment consumables in China and internationally. It offers electronic digestive endoscopes, otolaryngoscopes, bronchoscopes, and endoscopic diagnostic and treatment consumables for use in respiratory medicine, general … Read more